UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 27, 2011
IMAGING3, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
CALIFORNIA
----------------------------------------------
(State or other jurisdiction of incorporation)
000-50099 95-4451059
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
3200 W. VALHALLA DR., BURBANK, CALIFORNIA 91505
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (818) 260-0930
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions.
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR240.14d-2(b))
[_] Soliciting material pursuant to Rule 14a-12 under Exchange Act (17
CFR240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR240.13e-4(c))
TABLE OF CONTENTS
SECTION 8. OTHER EVENTS......................................................1
Item 8.01 Other Events.................................1
SECTION 9. FINANCIAL STATEMENTS AND EXHIBITS ................................1
SIGNATURES.....................................................................1
SECTION 8. OTHER EVENTS
Item 8.01. Other Events.
Effective on February 22, 2011, the consulting agreement between
Imaging3, Inc. (the "Company") and McDermott Will & Emery in connection with the
Company's application to the United States Food and Drug Administration was
terminated. Imaging3, Inc. engaged a new consultant for that purpose in March
2011.
SECTION 9. FINANCIAL STATEMENTS, PRO FORMA FINANCIALS & EXHIBITS
(a) Financial Statements of Business Acquired
Not Applicable.
(b) Pro Forma Financial Information
Not Applicable.
(c) Shell Company Transactions
Not Applicable.
(d) Exhibits
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
IMAGING3, INC.
----------------------------
(Registrant)
Date: April 27, 2011
/s/ Dean Janes, Chief Executive Officer
-------------------------------------------------
Dean Janes, Chief Executive Officer
-1
